# Samjin Pharmaceutical Co., Ltd.

Organization · id `cardio:org-samjin-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Samjin+Pharmaceutical+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Samjin Pharmaceutical Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI (`cardio:ct-nct02859480`)
- Sponsors: A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke (`cardio:ct-nct05301712`)
- Sponsors: Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) (`cardio:ct-nct05845489`)
- Sponsors: Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE (`cardio:ct-nct05995600`)
- Sponsors: Clopidogrel Versus Cilostazol on Vessels (`cardio:ct-nct06402747`)
- Sponsors: Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (`cardio:ct-nct06767774`)
- Sponsors: Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR) (`cardio:ct-nct07735130`)

## Provenance

Content hash: f629ee2875e39ffa1bc2a57180690e5eb3768df0b65f288fe1c896fb64774fb2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
